ロード中...
MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies
Immunotherapies have emerged to treat diseases by selectively modulating a patient’s immune response. Although the roles of T and B cells in adaptive immunity have been well studied, it remains difficult to select targets for immunotherapeutic strategies. Because human leukocyte antigen class II (HL...
保存先:
| 出版年: | Mol Cell Proteomics |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Biochemistry and Molecular Biology
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8327157/ https://ncbi.nlm.nih.gov/pubmed/34146720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mcpro.2021.100116 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|